Abstract:Various pathogenic variants in both mitochondrial tRNAPhe and Phenylalanyl-tRNA synthetase mitochondrial protein coding gene (FARS2) gene encoding for the human mitochondrial PheRS have been identified and associated with neurological and/or muscle-related pathologies. An important Guanine-34 (G34)A anticodon mutation associated with myoclonic epilepsy with ragged red fibers (MERRF) syndrome has been reported in hmit-tRNAPhe . The majority of G34 contacts in available aaRSs-tRNAs complexes specifically use that base as an important tRNA identity element. The network of intermolecular interactions providing its specific recognition also largely conserved. However, their conservation depends also on the invariance of the residues in the anticodon binding domain (ABD) of human mitochondrial Phenylalanyl-tRNA synthetase (hmit-PheRS). A defect in recognition of the anticodon of tRNAPhe may happen not only because of G34A mutation, but also due to mutations in the ABD. Indeed, a pathogenic mutation in FARS2 has been recently reported in a 9-year-old female patient harboring a p.Asp364Gly mutation. Asp364 is hydrogen bonded (HB) to G34 in WT hmit-PheRS. Thus, there are two pathogenic variants disrupting HB between G34 and Asp364: one is associated with G34A mutation, and the other with Asp364Gly mutation. We have measured the rates of tRNAPhe aminoacylation catalyzed by WT hmit-PheRS and mutant enzymes. These data ranked the residues making a HB with G34 according to their contribution to activity and the signal transduction pathway in the hmit-PheRS-tRNAPhe complex. Furthermore, we carried out extensive MD simulations to reveal the interdomain contact topology on the dynamic trajectories of the complex, and gaining insight into the structural and dynamic integrity effects of hmit-PheRS complexed with tRNAPhe . DATABASE: Structural data are available in PDB database under the accession number(s): 3CMQ, 3TUP, 5MGH, 5MGV.

Allosteric Mechanism of Human Mitochondrial Phenylalanyl-tRNA Synthetase: An Atomistic MD Simulation and a Mutual Information-Based Network Study

The G3-U70-independent tRNA recognition by human mitochondrial alanyl-tRNA synthetase.

Multilevel Functional and Structural Defects Induced by Two Pathogenic Mitochondrial Trna Mutations

Structural basis for shape-selective recognition and aminoacylation of a D-armless human mitochondrial tRNA

Breaking a single hydrogen bond in the mitochondrial tRNAPhe -PheRS complex leads to phenotypic pleiotropy of human disease

Alternative stable conformation capable of protein misinteraction links tRNA synthetase to peripheral neuropathy.

Structural basis for aminoacylation of cellular modified tRNA by human lysyl-tRNA synthetase

Orthogonal Use of a Human Trna Synthetase Active Site to Achieve Multifunctionality

New Substrates and Determinants for Trna Recognition of RNA Methyltransferase DNMT2/TRDMT1

Amino acid activation analysis of primitive aminoacyl-tRNA synthetases encoded by both strands of a single gene using the malachite green assay

Three human aminoacyl-tRNA synthetases have distinct sub-mitochondrial localizations that are unaffected by disease-associated mutations.

Elucidating the influence of RNA modifications and Magnesium ions on tRNA Phe conformational dynamics in S. cerevisiae : Insights from Replica Exchange Molecular Dynamics simulations

Structural and Mutational Studies of the Amino Acid-Editing Domain from Archaeal/eukaryal Phenylalanyl-Trna Synthetase.

Localization and RNA Binding of Mitochondrial Aminoacyl tRNA Synthetases

Atomistic Kinetic Model for Population Shift and Allostery in Biomolecules

Evolutionary Gain of Alanine Mischarging to Noncognate Trnas with A G4:U69 Base Pair

The Canonical and Noncanonical Functions of Aminoacyl-tRNA Synthetases

The uniqueness of AlaRS and its human disease connections

Overexpression of Human Mitochondrial Alanyl-Trna Synthetase Suppresses Biochemical Defects of the Mt-Trna(ala) Mutation in Cybrids

Structural insights into the specific recognition of mitochondrial ribosome-binding factor hsRBFA and 12 S rRNA by methyltransferase METTL15

CMT disease severity correlates with mutation-induced open conformation of histidyl-tRNA synthetase, not aminoacylation loss, in patient cells